Literature DB >> 29725525

Intake of phytic acid and myo-inositol lowers hepatic lipogenic gene expression and modulates gut microbiota in rats fed a high-sucrose diet.

Yukako Okazaki1, Ayaka Sekita1, Tetsuyuki Katayama2.   

Abstract

Dietary phytic acid (PA) was recently reported by our group to suppress hepatic lipogenic gene expression and modulate gut microbiota in rats fed a high-sucrose (HSC) diet. The present study aimed to investigate whether the modulatory effects of PA depend on the dietary carbohydrate source and are attributed to the myo-inositol (MI) ring of PA. Male Sprague-Dawley rats were fed an HSC or a high-starch (HSR) diet with or without 1.02% sodium PA for 12 days. Subsequently, the rats were fed the HSC diet, the HSC diet containing 1.02% sodium PA or an HSC diet containing 0.2% MI for 12 days. The HSC diet significantly increased the hepatic triglyceride (TG) concentration as well as the activity and expression of hepatic lipogenic enzymes compared with the HSR diet. The increases were generally suppressed by dietary PA with a concomitant increase in the fecal and cecal ratios of Lactobacillus spp. In rats fed the HSR diet, PA intake did not substantially affect the factors associated with hepatic lipid metabolism or gut microbiota composition. The effects of MI intake were similar to that of PA intake on hepatic lipogenesis and gut microbiota in rats fed the HSC diet. These results suggest that dietary PA downregulates hepatic lipogenic gene expression and modulates gut microbiota composition in rats fed an HSC diet but not in rats fed an HSR diet. The MI ring of PA may be responsible for the effects of PA intake on hepatic lipogenic gene expression and gut microbiota.

Entities:  

Keywords:  Lactobacillus spp.; fatty liver; gut microbiota; hepatic lipogenic gene expression; high-sucrose diet; myo-inositol; phytic acid

Year:  2018        PMID: 29725525      PMCID: PMC5920403          DOI: 10.3892/br.2018.1079

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  25 in total

Review 1.  Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics.

Authors:  Steven F Solga; A M Diehl
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

2.  Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine.

Authors:  H Hara; S Haga; Y Aoyama; S Kiriyama
Journal:  J Nutr       Date:  1999-05       Impact factor: 4.798

3.  Soy protein and fish oil independently decrease serum lipid concentrations but interactively reduce hepatic enzymatic activity and gene expression involved in fatty acid synthesis in rats.

Authors:  Yoko Takahashi
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  2011       Impact factor: 2.000

4.  Effects of dietary carbohydrate and myo-inositol on metabolic changes in rats fed 1,1,1-trichloro-2,2-bis (p-chlorophenyl) ethane (DDT).

Authors:  Yukako Okazaki; Tetsuyuki Katayama
Journal:  J Nutr Biochem       Date:  2003-02       Impact factor: 6.048

5.  Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Giacomo Zoppini; Luca Scala; Luciano Zenari; Giancarlo Falezza
Journal:  Clin Endocrinol (Oxf)       Date:  2006-06       Impact factor: 3.478

6.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.

Authors:  Aimin Xu; Yu Wang; Hussila Keshaw; Lance Yi Xu; Karen S L Lam; Garth J S Cooper
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  [3H]phytic acid (inositol hexaphosphate) is absorbed and distributed to various tissues in rats.

Authors:  K Sakamoto; I Vucenik; A M Shamsuddin
Journal:  J Nutr       Date:  1993-04       Impact factor: 4.798

Review 8.  Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic.

Authors:  Ivana Vucenik; AbulKalam M Shamsuddin
Journal:  J Nutr       Date:  2003-11       Impact factor: 4.798

9.  Dietary phytic acid prevents fatty liver by reducing expression of hepatic lipogenic enzymes and modulates gut microflora in rats fed a high-sucrose diet.

Authors:  Ayaka Sekita; Yukako Okazaki; Tetsuyuki Katayama
Journal:  Nutrition       Date:  2016-01-13       Impact factor: 4.008

10.  Effect of dietary level of phytic acid on hepatic and serum lipid status in rats fed a high-sucrose diet.

Authors:  Shoko Onomi; Yukako Okazaki; Tetsuyuki Katayama
Journal:  Biosci Biotechnol Biochem       Date:  2004-06       Impact factor: 2.043

View more
  1 in total

1.  Mucosal Bacteria Modulate Candida albicans Virulence in Oropharyngeal Candidiasis.

Authors:  M Bertolini; R Vazquez Munoz; L Archambault; S Shah; J G S Souza; R C Costa; A Thompson; Y Zhou; T Sobue; A Dongari-Bagtzoglou
Journal:  mBio       Date:  2021-08-17       Impact factor: 7.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.